PURPOSE OF REVIEW: Mitomycin-C is an antimetabolite that has seen increased use in ophthalmology over the past several decades. From glaucoma surgery to the management of various corneal disorders, mitomycin-C seems to be a viable tool in the management of scar and haze formation. RECENT FINDINGS: With the constant evolution of refractive surgery, mitomycin-C has come to the forefront as a modulator of corneal wound healing after excimer laser surface ablation. SUMMARY: This article will describe the various indications, techniques, and current trends of mitomycin-C application in corneal refractive surgery.
No takes yet. Share an insight, caveat, or question.
Lacayo et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: